These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Renal transplantation in the amyloidosis of familial Mediterranean fever. Experience in ten cases. Jacob ET; Bar-Nathan N; Shapira Z; Gafni J Arch Intern Med; 1979 Oct; 139(10):1135-8. PubMed ID: 384952 [TBL] [Abstract][Full Text] [Related]
31. A renal transplant recipient with delayed gastric emptying in amyloidosis due to familial Mediterranean fever improved with erythromycin: a case report. Saglam F; Celik A; Cavdar C; Sifil A; Atila K; Kaya GC; Bora S; Gulay H; Camsari T Transplant Proc; 2008; 40(1):308-9. PubMed ID: 18261613 [TBL] [Abstract][Full Text] [Related]
32. Renal transplantation in patients with amyloidosis due to familial Mediterranean fever. Shmueli D; Lustig S; Nakache R; Yussim A; Bar-Nathan N; Shaharabani E; Shapira Z Transplant Proc; 1992 Oct; 24(5):1783-4. PubMed ID: 1412842 [No Abstract] [Full Text] [Related]
33. Risk factors for amyloidosis and impact of kidney transplantation on the course of familial Mediterranean fever. Ben-Zvi I; Danilesko I; Yahalom G; Kukuy O; Rahamimov R; Livneh A; Kivity S Isr Med Assoc J; 2012 Apr; 14(4):221-4. PubMed ID: 22675837 [TBL] [Abstract][Full Text] [Related]
34. Posttransplant De Novo Hepatitis C Virus Infection in Renal Transplant Recipients: Its Impact on Morbidity and Mortality. Hanif FM; Laeeq SM; Luck NH; Aziz T; Abbas Z; Mubarak M Exp Clin Transplant; 2017 Feb; 15(1):56-60. PubMed ID: 27915964 [TBL] [Abstract][Full Text] [Related]
35. Effect of amyloidosis on long-term survival in kidney transplantation. Emiroglu R; Başaran O; Pehlivan S; Ozdemir FN; Colak T; Moray G; Noyan T; Haberal M Transplant Proc; 2005 Sep; 37(7):2967-8. PubMed ID: 16213276 [TBL] [Abstract][Full Text] [Related]
36. Incidence of infectious complications in highly sensitized renal transplant recipients treated by rituximab: a case-controlled study. Scemla A; Loupy A; Candon S; Mamzer MF; Martinez F; Zuber J; Sberro R; Legendre C; Thervet E Transplantation; 2010 Dec; 90(11):1180-4. PubMed ID: 20885337 [TBL] [Abstract][Full Text] [Related]
38. Transplantation within the era of anti-IL-1 therapy: case series of five patients with familial Mediterranean fever-related amyloidosis. Özçakar ZB; Keven K; Çakar N; Yalçınkaya F Transpl Int; 2018 Oct; 31(10):1181-1184. PubMed ID: 29957882 [No Abstract] [Full Text] [Related]
39. Conversion to everolimus in kidney transplant recipients: to believe or not believe? Cotovio P; Neves M; Santos L; Macário F; Alves R; Mota A Transplant Proc; 2012 Dec; 44(10):2966-70. PubMed ID: 23195007 [TBL] [Abstract][Full Text] [Related]
40. Long-term evaluation of neuromyopathy in live donor FMF amyloidotic kidney transplant recipients. Sherif AM; Refaie AF; Sheashaa HA; El-Tantawy AE; Sobh MA Am J Nephrol; 2004; 24(6):582-6. PubMed ID: 15557771 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]